Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention

doi:10.1097/TP.0000000000004170

. 2022 Aug 1;106(8):e380-e381.

doi: 10.1097/TP.0000000000004170. Epub 2022 Apr 20.

Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention

Kenji Okumura¹, Seigo Nishida¹, Abhay Dhand^{1

2}

Affiliations

¹ Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY.
² Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.

PMID: 35442246
PMCID: PMC9311289
DOI: 10.1097/TP.0000000000004170

Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention

Kenji Okumura et al. Transplantation. 2022.

. 2022 Aug 1;106(8):e380-e381.

doi: 10.1097/TP.0000000000004170. Epub 2022 Apr 20.

Authors

Kenji Okumura¹, Seigo Nishida¹, Abhay Dhand^{1

2}

Affiliations

¹ Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY.
² Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.

PMID: 35442246
PMCID: PMC9311289
DOI: 10.1097/TP.0000000000004170

No abstract available

PubMed Disclaimer

Conflict of interest statement

A.D. received an institutional research grant from Regeneron outside this work. The other authors declare no conflicts of interest.

Cited by

Outcomes of COVID-19 in kidney transplant recipients in the vaccination Era: A national multicenter cohort from Thailand.
Udomkarnjananun S, Kerr SJ, Banjongjit A, Phonphok K, Larpparisuth N, Vongwiwatana A, Noppakun K, Lumpaopong A, Supaporn T, Pongskul C, Avihingsanon Y, Townamchai N. Udomkarnjananun S, et al. Heliyon. 2023 Nov 24;9(12):e22811. doi: 10.1016/j.heliyon.2023.e22811. eCollection 2023 Dec. Heliyon. 2023. PMID: 38089989 Free PMC article.
Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study.
Banjongjit A, Phirom S, Phannajit J, Jantarabenjakul W, Paitoonpong L, Kittanamongkolchai W, Wattanatorn S, Prasithsirikul W, Eiam-Ong S, Avihingsanon Y, Hansasuta P, Vanichanan J, Townamchai N. Banjongjit A, et al. Vaccines (Basel). 2022 Oct 9;10(10):1685. doi: 10.3390/vaccines10101685. Vaccines (Basel). 2022. PMID: 36298550 Free PMC article.
COVID-19 in solid organ transplant recipients after 2 years of pandemic: Outcome and impact of antiviral treatments in a single-center study.
Pinchera B, Buonomo AR, Trucillo E, Susini S, D'Agostino A, Di Filippo I, Tanzillo A, Villari R, Carrano R, Troisi RI, Gentile I. Pinchera B, et al. Front Transplant. 2023 Mar 16;2:1095225. doi: 10.3389/frtra.2023.1095225. eCollection 2023. Front Transplant. 2023. PMID: 38993895 Free PMC article.
COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
Hedvat J, Lange NW, Salerno DM, DeFilippis EM, Kovac D, Corbo H, Chen JK, Choe JY, Lee JH, Anamisis A, Jennings DL, Codispodo G, Shertel T, Brown RS Jr, Pereira MR. Hedvat J, et al. Am J Transplant. 2022 Nov;22(11):2682-2688. doi: 10.1111/ajt.17140. Epub 2022 Jul 18. Am J Transplant. 2022. PMID: 35801839 Free PMC article.
Epidemiological and Clinical Characteristics of the Course of COVID-19 Among Vaccinated and Unvaccinated Heart Transplant Recipients in Slovenia.
Grasselli Kmet N, Mavrič M, Saletinger R. Grasselli Kmet N, et al. Vaccines (Basel). 2024 Dec 3;12(12):1366. doi: 10.3390/vaccines12121366. Vaccines (Basel). 2024. PMID: 39772027 Free PMC article.

See all "Cited by" articles

References

1. Callaghan CJ, Mumford L, Curtis RMK, et al. ; NHSBT Organ and Tissue Donation and Transplantation Clinical Team. Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and islet transplant recipients. Transplantation. 2022;106:436–446. - PMC - PubMed
1. Aslam S, Liu J, Sigler R, et al. . Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients. Transpl Infect Dis. 2022;24:e13788. - PMC - PubMed
1. Qin CX, Moore LW, Anjan S, et al. . Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021;105:e265–e266. - PMC - PubMed
1. Stumpf J, Siepmann T, Lindner T, et al. . Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9:100178. - PMC - PubMed
1. Hippen BE, Axelrod DA, Maher K, et al. . Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States. Am J Transplant. [Epub ahead of print. February 10, 2022]. doi:10.1111/ajt.16995 - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Callaghan CJ, Mumford L, Curtis RMK, et al. ; NHSBT Organ and Tissue Donation and Transplantation Clinical Team. Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and islet transplant recipients. Transplantation. 2022;106:436–446. - PMC - PubMed

[2] Callaghan CJ, Mumford L, Curtis RMK, et al. ; NHSBT Organ and Tissue Donation and Transplantation Clinical Team. Real-world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against SARS-CoV-2 in solid organ and islet transplant recipients. Transplantation. 2022;106:436–446. - PMC - PubMed

[3] Aslam S, Liu J, Sigler R, et al. . Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients. Transpl Infect Dis. 2022;24:e13788. - PMC - PubMed

[4] Aslam S, Liu J, Sigler R, et al. . Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients. Transpl Infect Dis. 2022;24:e13788. - PMC - PubMed

[5] Qin CX, Moore LW, Anjan S, et al. . Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021;105:e265–e266. - PMC - PubMed

[6] Qin CX, Moore LW, Anjan S, et al. . Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021;105:e265–e266. - PMC - PubMed

[7] Stumpf J, Siepmann T, Lindner T, et al. . Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9:100178. - PMC - PubMed

[8] Stumpf J, Siepmann T, Lindner T, et al. . Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9:100178. - PMC - PubMed

[9] Hippen BE, Axelrod DA, Maher K, et al. . Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States. Am J Transplant. [Epub ahead of print. February 10, 2022]. doi:10.1111/ajt.16995 - PMC - PubMed

[10] Hippen BE, Axelrod DA, Maher K, et al. . Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States. Am J Transplant. [Epub ahead of print. February 10, 2022]. doi:10.1111/ajt.16995 - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention

Affiliations

Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical